Page last updated: 2024-08-24

atorvastatin and Heart Valve Diseases

atorvastatin has been researched along with Heart Valve Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aibibula, A; Shabiti, A; Tuerxun, A; Wufuer, H1
Barbato, R; Barberi, F; Casacalenda, A; Chello, M; Colicchia, C; Di Lorenzo, D; Forte, F; Gaudino, M; Giacinto, O; Greco, SM; Lusini, M; Mastroianni, C; Miano, N; Nappi, F; Nenna, A; Pugliese, G; Satriano, U; Spadaccio, C1
Armstrong, ZB; Boughner, DR; Carruthers, CP; Drangova, M; Rogers, KA1
Angus, PW; Ekinci, EI; Gow, PJ; Jones, RM; O'Brien, RC; Page, MM1
de Ceuninck, M; Trenson, S1
Dehghani, MR; Kasianzadeh, M; Rezaei, Y; Sepehrvand, N1
Gao, X; Gu, G; Hu, W; Jin, S; Li, J; Li, Y; Wu, PH; Zhan, C; Zhang, L1
Bonow, RH; Bonow, RO; Caira, F; Makkena, B; Rajamannan, NM; Salti, H; Spelsberg, TC; Subramaniam, M; Thennapan, S1
Bonow, RO; Ignatiev, KI; McConnell, JP; Rajamannan, NM; Singh, RJ; Spelsberg, TC; Springett, M; Stock, SR; Stone, NJ; Subramaniam, M1
Bonow, RO; McConnell, JP; Niekrasz, M; Rajamannan, NM; Sebo, TC; Singh, RJ; Spelsberg, TC; Springett, M; Stone, NJ; Subramaniam, M1

Reviews

1 review(s) available for atorvastatin and Heart Valve Diseases

ArticleYear
Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.
    Internal medicine journal, 2014, Volume: 44, Issue:6

    Topics: Adult; Atorvastatin; Azetidines; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Consanguinity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Heptanoic Acids; Homozygote; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins, LDL; Liver Transplantation; Male; Pyrroles; Receptors, LDL

2014

Trials

1 trial(s) available for atorvastatin and Heart Valve Diseases

ArticleYear
Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial.
    Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:5

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Cardiac Surgical Procedures; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Valve Diseases; Humans; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Perioperative Care; Placebos

2015

Other Studies

8 other study(ies) available for atorvastatin and Heart Valve Diseases

ArticleYear
Therapeutic Effect and Mechanism of Action of Abnormal Savda Munziq in Development of Degenerative Atherosclerotic Aortic Valve Disease.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Sep-14, Volume: 23

    Topics: Animals; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Atorvastatin; Bicuspid Aortic Valve Disease; Calcinosis; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diet, High-Fat; Drugs, Chinese Herbal; Heart Defects, Congenital; Heart Valve Diseases; Male; Medicine, Traditional; Plant Extracts; Rabbits; Triglycerides

2017
Preoperative atorvastatin reduces bleeding and blood transfusions in patients undergoing elective isolated aortic valve replacement.
    Interactive cardiovascular and thoracic surgery, 2019, 07-01, Volume: 29, Issue:1

    Topics: Aged; Anticholesteremic Agents; Aortic Valve; Atorvastatin; Blood Transfusion; Cardiac Surgical Procedures; Elective Surgical Procedures; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Incidence; Italy; Male; Postoperative Hemorrhage; Preoperative Care; Retrospective Studies

2019
Effects of an angiotensin II type 1 receptor blocker on aortic valve sclerosis in a preclinical model.
    The Canadian journal of cardiology, 2014, Volume: 30, Issue:9

    Topics: Angiotensin Receptor Antagonists; Animals; Aortic Valve; Atorvastatin; Bicuspid Aortic Valve Disease; Disease Progression; Heart Defects, Congenital; Heart Valve Diseases; Heptanoic Acids; Imidazoles; Immunohistochemistry; Male; Pyrroles; Rabbits; Random Allocation; Sclerosis; Tetrazoles

2014
A calcified left ventricular mass.
    Acta cardiologica, 2014, Volume: 69, Issue:3

    Topics: Aged, 80 and over; Aging; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Calcinosis; Diagnosis, Differential; Female; Heart Neoplasms; Heart Valve Diseases; Heptanoic Acids; Humans; Hypertension; Mitral Valve; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Pyrroles; Quinapril; Radiography; Tetrahydroisoquinolines; Treatment Outcome

2014
The effect of oxLDL on aortic valve calcification via the Wnt/ β-catenin signaling pathway: an important molecular mechanism.
    The Journal of heart valve disease, 2015, Volume: 24, Issue:2

    Topics: Animals; Aortic Valve; Apoptosis; Atorvastatin; Bicuspid Aortic Valve Disease; Blotting, Western; Calcinosis; Cells, Cultured; Heart Defects, Congenital; Heart Valve Diseases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Myofibroblasts; Pyrroles; Swine; Wnt Signaling Pathway

2015
Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve.
    Journal of the American College of Cardiology, 2005, Feb-15, Volume: 45, Issue:4

    Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bone Matrix; Calcinosis; Cell Division; Heart Valve Diseases; Heptanoic Acids; Hypercholesterolemia; Male; Mitral Valve; Pyrroles; Rabbits

2005
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve.
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:6

    Topics: Animals; Anticholesteremic Agents; Aortic Valve; Atorvastatin; Blotting, Western; C-Reactive Protein; Calcinosis; Cholesterol; Heart Valve Diseases; Heptanoic Acids; Hypercholesterolemia; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Pyrroles; Rabbits; Tomography, X-Ray Computed

2005
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.
    Circulation, 2002, Jun-04, Volume: 105, Issue:22

    Topics: Alkaline Phosphatase; Animals; Anticholesteremic Agents; Aortic Valve; Atorvastatin; Biomarkers; C-Reactive Protein; Calcinosis; Cell Division; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Heart Valve Diseases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunohistochemistry; Macrophages; Male; Microscopy, Immunoelectron; Osteoblasts; Osteopontin; Proliferating Cell Nuclear Antigen; Pyrroles; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins

2002